Back
Day Range
$12.99
$13.82
52-Week Range
$2.54
$26.95
Volume
1,179,540
50D / 200D Avg
$16.97
/
$8.91
Prev Close
$13.75
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -72.3 | 0.4 |
| P/B | 18.1 | 2.9 |
| ROE % | -32.6 | 3.9 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$31.80
+141.8%
Low: $27.00
High: $42.00
Forward EPS
-$0.69
Est. Revenue
1.2 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.12
$0.10 – $0.14
|
240 M | 2 |
| FY2029 |
-$0.46
-$0.53 – -$0.38
|
130 M | 4 |
| FY2028 |
-$0.64
-$1.56 – $0.05
|
58 M | 6 |
Key Takeaways
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -32.97M
PEG of 0.49 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-32.60%
ROIC-51.86%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.02
Current Ratio6.21
Interest Coverage0.00
Valuation
P/E Ratio
-72.27
P/B Ratio18.05
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -15.28M |
| ROE | -32.60% | ROA | -21.49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32.97M |
| ROIC | -51.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 6.21 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -72.27 | P/B Ratio | 18.05 |
| P/S Ratio | N/A | PEG Ratio | 0.49 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.10B | Enterprise Value | 1.10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -15.28M | -62.29M | -27.03M | -41.31M | -43.24M |
| EPS (Diluted) | -0.53 | -1.02 | -0.56 | -0.89 | -1.03 |
| Gross Profit | -105,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -42.97M | -27.55M | -23.41M | -32.57M | -38.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 71.12M | 68.91M | 45.55M | 68.24M | 109.46M |
| Total Liabilities | 9.91M | 36.34M | 6.87M | 12.13M | 12.29M |
| Shareholders' Equity | 61.21M | 32.57M | 38.68M | 56.12M | 97.16M |
| Total Debt | 937,000.0 | 1.12M | 1.37M | 2.60M | 3.65M |
| Cash & Equivalents | 4.58M | 8.74M | 12.62M | 13.16M | 63.46M |
| Current Assets | 58.21M | 54.41M | 27.96M | 43.66M | 71.31M |
| Current Liabilities | 9.38M | 35.40M | 6.87M | 10.75M | 9.69M |